H
HealthTide Biotech
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | C | 6 | 7.6 | 4.4 | 10.0 | 5 Aug 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 |
| Adipotide | X | 1 | 9.8 | 9.8 | 9.8 | 27 Feb 2025 |
| Anadrol Oil | X | 1 | 7.8 | 7.8 | 7.8 | 13 Feb 2025 |
| Andarine S4 | X | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | X | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 |
| Blend 300 (TRA/Mast P/Test P) | X | 1 | 9.1 | 9.1 | 9.1 | 3 Jun 2025 |
| Botulinum toxin | X | 1 | 8.8 | 8.8 | 8.8 | 13 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 8.1 | 8.1 | 8.1 | 25 Apr 2025 |
| Bronchogen | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 |
| Cartalax | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| CJC-1295 With DAC | X | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 6.9 | 6.9 | 6.9 | 2 Jul 2025 |
| Clomiphene (Clomid) Raw | X | 1 | 8.3 | 8.3 | 8.3 | 16 Mar 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 5.5 | 5.5 | 5.5 | 13 Feb 2025 |
| EPO | X | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X | 1 | 5.5 | 5.5 | 5.5 | 13 Jun 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 9.0 | 9.0 | 9.0 | 8 Jul 2025 |
| MGF | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Minoxidil Oral | X | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 |
| MOTS-C | X | 1 | 5.9 | 5.9 | 5.9 | 9 Jun 2025 |
| P21 | X | 1 | 9.4 | 9.4 | 9.4 | 13 Jun 2025 |
| Pinealon | X | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 |
| PTD-DBM | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 8.0 | 8.0 | 8.0 | 9 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 |
| Selank | X | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Semaglutide Oral | X | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 |
| Tamoxifen (Nolvadex) | X | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 |
| Test Suspension | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| Tren Hex | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| TriTren 225 | X | 1 | 7.1 | 7.1 | 7.1 | 27 Feb 2025 |
| Vesugen | X | 1 | 7.8 | 7.8 | 7.8 | 7 May 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | DHB (1-Test Cyp) Oral | 4.6 | 100mg | 110.0mg | +10.0% | 98.00% | Lab G |
| 24 May 2026 | Selank | 5.5 | 5mg | 4.4mg | -12.8% | 96.73% | Lab E |
| 24 May 2026 | Clomiphene (Clomid) Raw | 6.4 | 5g | 4.5g | -10.1% | 96.31% | Lab G |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 9.3 | 10mg | 9.2mg | -8.3% | 96.26% | Lab B |
| 24 May 2026 | EPO | 7.1 | 20mg | 18.9mg | -5.3% | 96.29% | Lab G |
| 23 May 2026 | Tirzepatide | 10.0 | 30mg | 31.3mg | +4.3% | 99.88% | Lab E |
| 23 May 2026 | Semaglutide Oral | 8.4 | 100mg | 112.2mg | +12.2% | 99.04% | Lab C |
| 23 May 2026 | Tren Hex | 6.3 | 300mg/ml | 268.9mg/ml | -10.4% | 97.32% | Lab E |
| 21 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.9 | 10mg | 11.6mg | +16.1% | 97.45% | Lab A |
| 21 May 2026 | Andarine S4 | 7.0 | 25mg | 30.5mg | +21.9% | 96.48% | Lab B |
| 20 May 2026 | Blend 300 (TRA/Mast P/Test P) | 8.3 | 250mg/ml | 287.1mg/ml | +14.8% | 97.34% | Lab D |
| 19 May 2026 | Test Suspension | 5.5 | 300mg/ml | 357.9mg/ml | +19.3% | 95.87% | Lab B |
| 17 May 2026 | Adipotide | 10.0 | 50mg | 46.9mg | -6.2% | 95.45% | Lab E |
| 17 May 2026 | Tamoxifen (Nolvadex) | 8.5 | 20mg | 22.1mg | +10.6% | 99.17% | Lab C |
| 26 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 8.4 | 50mg | 51.7mg | +3.5% | 98.20% | Lab E |
| 26 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.8 | 10mg | 10.9mg | +9.4% | 99.91% | Lab A |
| 9 Jan 2026 | Bronchogen | 4.0 | 2mg | 2.3mg | +15.8% | 96.43% | Lab B |
| 7 Jan 2026 | Anadrol Oil | 8.3 | 300mg/ml | 323.0mg/ml | +7.7% | 96.33% | Lab E |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 10.0 | 2mg | 2.3mg | +13.0% | 97.22% | Lab F |
| 6 Jan 2026 | Pinealon | 4.6 | 50mg | 55.5mg | +11.0% | 95.14% | Lab E |
| 29 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.7 | 500g | 621.1g | +24.2% | 98.86% | Lab A |
| 29 Dec 2025 | MOTS-C | 7.0 | 5mg | 5.4mg | +8.0% | 96.42% | Lab A |
| 17 Dec 2025 | Tirzepatide | 9.4 | 10mg | 9.32mg | -6.8% | 99.95% | Lab E |
| 17 Nov 2025 | CJC-1295 With DAC | 7.5 | 30mg | 28.5mg | -5.0% | 96.08% | Lab E |
| 14 Nov 2025 | Vesugen | 7.9 | 10mg | 12.5mg | +24.9% | 96.15% | Lab A |
| 5 Nov 2025 | Cartalax | 6.3 | 5mg | 4.9mg | -2.3% | 99.24% | Lab F |
| 5 Nov 2025 | TriTren 225 | 6.9 | 250mg/ml | 250.7mg/ml | +0.3% | 98.25% | Lab F |
| 4 Nov 2025 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 4.0 | 250mg/ml | 288.5mg/ml | +15.4% | 98.22% | Lab D |
| 4 Nov 2025 | MGF | 7.9 | 10mg | 9.0mg | -10.4% | 99.56% | Lab A |
| 9 Oct 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 7.4 | 5g | 6.0g | +20.7% | 98.83% | Lab B |
| 9 Oct 2025 | Botulinum toxin | 9.6 | 2mg | 2.1mg | +4.4% | 96.59% | Lab C |
| 9 Oct 2025 | P21 | 8.9 | 2mg | 1.9mg | -2.5% | 95.97% | Lab A |
| 9 Oct 2025 | Selank 10mg + Semax 10mg Blend | 7.6 | 2mg | 2.0mg | -0.2% | 95.24% | Lab A |
| 3 Oct 2025 | Minoxidil Oral | 6.5 | 50mg | 60.1mg | +20.2% | 98.00% | Lab A |
| 3 Oct 2025 | PTD-DBM | 9.3 | 5mg | 5.6mg | +11.4% | 96.36% | Lab F |
| 28 Aug 2025 | Tirzepatide | 8.0 | 30mg | 29.3mg | -2.3% | 99.88% | Lab E |
| 28 Aug 2025 | Tirzepatide | 8.0 | 30mg | 29.2mg | -2.7% | 99.89% | Lab E |
| 5 Aug 2025 | Tirzepatide | 4.4 | 20mg | 16.9mg | -15.5% | 86.05% | Lab E |
| 5 Aug 2025 | Tirzepatide | 6.1 | 20mg | 18.5mg | -7.5% | 92.03% | Lab E |